Postmarketing evaluation of the safety and effectiveness of varicella vaccine.
about
Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adultsVaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adultsChickenpox.Varicella vaccination--a critical review of the evidence.Fever following immunization.Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005.Vaccination to prevent varicella and shingles.Sero-Prevalence of Antibodies against Varicella Zoster Virus in Children under Seven-Years Old in 2012 in Tehran, Iran.Pharmacovigilance in children: detecting adverse drug reactions in routine electronic healthcare records. A systematic review.Canada's first universal varicella immunization program: Lessons from Prince Edward Island.Varicella vaccination in Australia.Varicella vaccine effectiveness in the US vaccination program: a review.Chickenpox vaccination, not chickenpox, should be routine for Canadian children.Three-year follow-up of protection rates in children given varicella vaccine.Lack of association between age at varicella vaccination and risk of breakthrough varicella, within the Northern California Kaiser Permanente Medical Care Program.Do the benefits of varicella vaccination outweigh the long-term risks? A decision-analytic model for policymakers and pediatricians.The case against universal varicella vaccination.Chickenpox
P2860
Q24193819-007B60F4-8A21-4D1A-ABC7-A99193E6619BQ24242809-65EA3C0B-20FE-43AD-94E3-9886002A6F9FQ33448298-DDCE4A61-FCB2-4255-9C08-A03D193771DDQ34315355-532AA851-9B4A-41A7-B940-BC9901761726Q34434824-32BDDBD1-2F35-4568-81E6-162180B35238Q34590637-153C4C23-29E0-4EFC-B228-F391FDEF6C7AQ35397475-72F2E21E-7D5B-46F6-9FB0-D880C40ABC7FQ35666726-0EC2FA0E-9F4C-4BC1-92EB-4EA20644FC77Q36125536-6124F7ED-99E3-48A3-BD52-A8F291D966D6Q36170655-CAA60D1C-2DB1-482B-A5D2-0C0E89B54304Q36362821-89A2874A-AAAE-46EB-820C-B1ED6CAC9854Q37141186-5C7BE860-0B5B-4A4A-8F66-25485DCAEA53Q39431987-077CF703-9355-473C-9229-AC5AD4F738F7Q39827157-2604B4DF-8BF6-4A59-99F0-7B450D8452C5Q44708060-25F9B4B5-5C62-4055-A4A7-93ECAD986AAEQ44739941-FC2D5E13-7CF5-4E62-A73B-04E25FAF7609Q46988238-1D4A59D3-520B-4D15-A7CB-238BBF169CFBQ56768016-FEE2EE29-E5E4-4826-B292-F45FFF1F1B9A
P2860
Postmarketing evaluation of the safety and effectiveness of varicella vaccine.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Postmarketing evaluation of the safety and effectiveness of varicella vaccine.
@ast
Postmarketing evaluation of the safety and effectiveness of varicella vaccine.
@en
type
label
Postmarketing evaluation of the safety and effectiveness of varicella vaccine.
@ast
Postmarketing evaluation of the safety and effectiveness of varicella vaccine.
@en
prefLabel
Postmarketing evaluation of the safety and effectiveness of varicella vaccine.
@ast
Postmarketing evaluation of the safety and effectiveness of varicella vaccine.
@en
P2093
P1476
Postmarketing evaluation of the safety and effectiveness of varicella vaccine.
@en
P2093
Schwalbe J
Shinefield H
P304
P356
10.1097/00006454-199912000-00003
P577
1999-12-01T00:00:00Z